ExLibris header image
SFX Logo
Title: Human and Helicobacter pylori coevolution shapes the risk of gastric disease
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Kodaman, N yr:2014


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Gagneux, S. "Host–pathogen coevolution in human tuberculosis." Philosophical transactions - Royal Society. Biological sciences 367.1590 (2012): 850-859. Link to SFX for this item
2. Ghoshal, Uday C. "The enigma of Helicobacter pylori infection and gastric cancer." Indian journal of gastroenterology 29.3 (2010): 95-100. Link to SFX for this item
3. Hiraishi, H. "Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection - the results of a multicentre, double-blind, randomised clinical trial (IMPACT study)." Alimentary pharmacology & therapeutics 31.8 (2010): 824-33. Link to Full Text for this item Link to SFX for this item
4. Hertz, T. "Mapping the Landscape of Host-Pathogen Coevolution: HLA Class I Binding and Its Relationship with Evolutionary Conservation in Human and Viral Proteins." Journal of virology 85.3 (2011): 1310-1321. Link to Full Text for this item Link to SFX for this item
5. Santos, S B. "Selection and characterization of a multivalent Salmonella phage and its production in a nonpathogenic Escherichia coli strain." Applied and environmental microbiology 76.21 (2010): 7338-7342. Link to Full Text for this item Link to SFX for this item
6. Gagneux, D. "Old and new selective pressures on Mycobacterium tuberculosis." Infection, genetics and evolution 12.4 (2011): 678-685. Link to SFX for this item
7. Perrin, P. "Human and tuberculosis co-evolution: An integrative view." Tuberculosis 95.Suppl. 1 (2015). Link to SFX for this item
8. Comas, I. "Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans." Nature 502.7470 (2013). Link to Full Text for this item Link to SFX for this item
9. Comas, I. "Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans." Nature Genetics 45.10 (2013): 1176-1182. Link to SFX for this item
10. Galvani, AP P. "Epidemiology meets evolutionary ecology." Trends in ecology & evolution 18.3 (2003): 132-139. Link to Full Text for this item Link to SFX for this item
11. Worobey, M. "Point, counterpoint: The evolution of pathogenic viruses and their human hosts." Annual Review of Ecology, Evolution, and Systematics 38.1 (2007): 515-540. Link to Full Text for this item Link to SFX for this item
12. Lee, Simon J. Craddock C. "Malignant: How Cancer Becomes Us." Anthropological quarterly 87.1 (2014): 255-267. Link to SFX for this item
13. Krawczyk, A. "Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody." Proceedings of the National Academy of Sciences of the United States of America 110.17 (2013): 6760-6765. Link to Full Text for this item Link to SFX for this item
14. Malfertheiner, P. "Helicobacter pylori eradication and gastric ulcer healing - Comparison of three pantoprazole-based triple therapies." Alimentary pharmacology & therapeutics 17.9 (2003): 1125-35. Link to Full Text for this item Link to SFX for this item
15. Scaduto, Diane I. "Source identification in two criminal cases using phylogenetic analysis of HIV-1 DNA sequences." Proceedings of the National Academy of Sciences of the United States of America 107.50 (2010): 21242-21247. Link to Full Text for this item Link to SFX for this item
16. Murakami, K. "Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy : a randomized, controlled, prospective study." Scandinavian journal of gastroenterology 46.3 (2011): 287-292. Link to SFX for this item
17. Higuchi, K. "Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist." Journal of gastroenterology and hepatology 25 Suppl 1.s1 (2010): 155-60. Link to SFX for this item
18. Peek, Richard M. "Role of innate immunity in Helicobacter pylori-induced gastric malignancy." Physiological reviews 90.3 (2010): 831-858. Link to SFX for this item
19. Fass, R. "Clinical trial: maintenance intermittent therapy with rabeprazole 20 mg in patients with symptomatic gastro-oesophageal reflux disease - a double-blind, placebo-controlled, randomized study." Alimentary pharmacology & therapeutics 31.9 (2010): 950-960. Link to Full Text for this item Link to SFX for this item
20. Graham, David Y. "African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths." Journal of Digestive Diseases 10.2 (2009): 77-84. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.